Epilepsy Society welcomes Government decision to relax licensing of medicinal cannabis
Please note that there are further updates to this news story which you can read at the links below:
Specialist doctors can now prescribe medicinal cannabis for epilepsy (1 November 2018)
Medicinal cannabis can now be prescribed by specialists for epilepsy (12 October 2018)
Protein found in worms helps to stop seizure activity
Exciting new research that involves using a protein in worms to suppress seizures, could spell hope in the future for thousands of people with epilepsy.
Epilepsy Society responds to reports of medicine stockpiling in advance of Brexit
Media reports in recent weeks have indicated that some UK pharmaceutical companies are stockpiling medicines in preparation for a possible hard Brexit in 2019.
Tribunal overrules findings in case involving epilepsy drug
A decision by the Competition and Markets Authority to fine Pfizer and Flynn Pharma a total of £90m for overcharging for an epilepsy drug, has been remitted back to the CMA after a tribunal ruled against the government watchdog's decision.
Clare Pelham comments on new sodium valproate regulations
Our chief executive Clare Pelham, a member of the Commission on Human Medicines' Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.
Charity tells health secretary new drug regulations could fail without public campaign
Epilepsy Society today welcomes new regulatory measures to stop babies being born with avoidable disabilities after being exposed to the drug, sodium valproate, in the womb.